Bleeding control using intrauterine continuous running suture during cesarean section in pregnant women with placenta previa
- 180 Downloads
The purpose of this study was to evaluate the effectiveness of intrauterine continuous running suture during cesarean section in pregnant women with placenta previa.
We enrolled 277 women and medical records were retrospectively reviewed. Pregnant women were grouped according to uterine bleeding control methods as follows: Group A, using intrauterine continuous running suture and Group B (control group) using figure-of-eight suture.
Intrauterine continuous running sutures were used in 104 pregnant women. Mean total blood loss in Group A was significantly less than that in Group B (1332.70 ± 152.92 mL vs 1861.56 ± 157.74 mL, P = 0.029). Mean total transfusion unit of Group A was significantly less than that in Group B (1.74 ± 0.41 vs 3.52 ± 0.75, P = 0.037).
Intrauterine continuous running sutures can significantly reduce postpartum blood loss and transfusion units during cesarean section in pregnant women with placenta previa.
KeywordsIntrauterine continuous running suture Placenta previa Postpartum hemorrhage Transfusion
We can obtained good data through the efforts of one of the surgeons (Seong Yeon Hong) of Table 4.
JMR MD conducted data collection, analysis, and manuscript writing. YSC MD, PhD conducted project development and data analysis of study. JYB MD, PhD conducted project development and manuscript writing.
Compliance with ethical standards
Conflict of interest
There are no conflicts of interest to declare.
This retrospective study was approved by the Institutional Ethics Committee of Daegu Catholic University hospital Ethical approval. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent was obtained from all individual participants included in the study.
- 2.WHO (2012) WHO recommendations for the prevention and treatment of postpartum haemorrhage. WHO, GenevaGoogle Scholar
- 4.Widmer M, Blum J, Hofmeyr GJ, Carroli G, Abdel-Aleem H, Lumbiganon P, Nguyen TN, Wojdyla D, Thinkhamrop J, Singata M, Mignini LE, Abdel-Aleem MA, Tran ST, Winikoff B (2010) Misoprostol as an adjunct to standard uterotonics for treatment of post-partum haemorrhage: a multicentre, double-blind randomised trial. Lancet 375(9728):1808–1813CrossRefPubMedGoogle Scholar